Peripheral T Cell Lymphoma Clinical Trials in Hangzhou, Zhejiang
4 recruitingHangzhou, Zhejiang, China
Showing 1–4 of 4 trials
Recruiting
Phase 1Phase 2
Evaluate the Safety and Clinical Activity of HH2853
Advanced Solid TumorPeripheral T Cell LymphomaFL Lymphoma+1 more
Haihe Biopharma Co., Ltd.254 enrolled25 locationsNCT04390737
Recruiting
Phase 1Phase 2
Linperlisib Combined With Chidamide in Patients With PTCL
Peripheral T Cell Lymphoma
Yanyan Liu134 enrolled6 locationsNCT06421948
Recruiting
Phase 3
A Phase 3 Multinational Study of Golidocitinib Versus Investigator's Choice in r/r PTCL (JACKPOT19)
Peripheral T Cell Lymphoma
Dizal Pharmaceuticals218 enrolled50 locationsNCT07234162
Recruiting
Phase 2
Efficacy and Safety of Lenalidomide Plus CHOP vs CHOP in Patients With Untreated Peripheral T-Cell Lymphoma
Peripheral T Cell LymphomaLenalidomideCHOP
Second Affiliated Hospital, School of Medicine, Zhejiang University289 enrolled1 locationNCT04922567